Can lesion volume and prostate-specific antigen density play a role in detecting clinically significant prostate cancer in Prostate Imaging Reporting and Data System-3 lesions on multiparametric magnetic resonance imaging?

Introduction: Recently, the Prostate Imaging Reporting and Data System – 3 lesions (PI-RADS 3) have been sub classified into “3a” - lesions with a volume of <0.5 mL and “3b” - lesions exceeding 0.5 mL, whereas the prostate-specific antigen density (PSAD) is an established adjunct tool for predict...

Full description

Saved in:
Bibliographic Details
Main Authors: Shashank Agrawal, Vishnu Prasad, Arun Ramadas Menon, Ginil Kumar Pooleri
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Indian Journal of Urology
Online Access:https://journals.lww.com/10.4103/iju.iju_112_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849705658453065728
author Shashank Agrawal
Vishnu Prasad
Arun Ramadas Menon
Ginil Kumar Pooleri
author_facet Shashank Agrawal
Vishnu Prasad
Arun Ramadas Menon
Ginil Kumar Pooleri
author_sort Shashank Agrawal
collection DOAJ
description Introduction: Recently, the Prostate Imaging Reporting and Data System – 3 lesions (PI-RADS 3) have been sub classified into “3a” - lesions with a volume of <0.5 mL and “3b” - lesions exceeding 0.5 mL, whereas the prostate-specific antigen density (PSAD) is an established adjunct tool for predicting clinically significant prostate cancer (csPCa). The objective of this study was to evaluate the association between the volume of PI-RADS 3 lesions and PSAD in diagnosing csPCa and to assess the sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) when PSAD is combined with the lesion volume. Methods: This retrospective single-center study reviewed the data of transperineal prostate biopsies performed under transrectal ultrasound guidance from January 2018 to December 2023. csPCa was defined as a Gleason score ≥3 + 4. Patients were divided into two groups based on the PIRADS-3 subclassification and PSAD. Results: Out of the 108 PIRADS-3 lesions, 17 patients had csPCa. All the patients with PIRADS-3a (n = 37) had clinically insignificant tumors or benign conditions. Receiver operating characteristic curve analysis for predicting csPCa showed that the (Area under the curve) AUC values of PSAD, prostate volume, and prostate-specific antigen were 0.899, 0.746, and 0.381, respectively. 16 csPCa patients in PIRADS-3b category had PSAD ≥0.29 ng/ml2, whereas 1 patient had PSAD <0.29 ng/ml2. Sensitivity, specificity, PPV, and NPV of PIRADS-3b lesions were 100%, 40.66%, 23.94%, and 100%, respectively, and it became 94.12%, 74.07%, 53.33%, and 97.56%, respectively, when PSAD was added to PIRADS-3b lesions. Conclusion: The combination of lesion volume of the PI-RADS 3 lesion and PSAD improved the PPV and specificity of detecting csPCa.
format Article
id doaj-art-0a2a3cd22f0b48eeb1062aa3d6fc2223
institution DOAJ
issn 0970-1591
1998-3824
language English
publishDate 2025-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Urology
spelling doaj-art-0a2a3cd22f0b48eeb1062aa3d6fc22232025-08-20T03:16:24ZengWolters Kluwer Medknow PublicationsIndian Journal of Urology0970-15911998-38242025-01-01411353910.4103/iju.iju_112_24Can lesion volume and prostate-specific antigen density play a role in detecting clinically significant prostate cancer in Prostate Imaging Reporting and Data System-3 lesions on multiparametric magnetic resonance imaging?Shashank AgrawalVishnu PrasadArun Ramadas MenonGinil Kumar PooleriIntroduction: Recently, the Prostate Imaging Reporting and Data System – 3 lesions (PI-RADS 3) have been sub classified into “3a” - lesions with a volume of <0.5 mL and “3b” - lesions exceeding 0.5 mL, whereas the prostate-specific antigen density (PSAD) is an established adjunct tool for predicting clinically significant prostate cancer (csPCa). The objective of this study was to evaluate the association between the volume of PI-RADS 3 lesions and PSAD in diagnosing csPCa and to assess the sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) when PSAD is combined with the lesion volume. Methods: This retrospective single-center study reviewed the data of transperineal prostate biopsies performed under transrectal ultrasound guidance from January 2018 to December 2023. csPCa was defined as a Gleason score ≥3 + 4. Patients were divided into two groups based on the PIRADS-3 subclassification and PSAD. Results: Out of the 108 PIRADS-3 lesions, 17 patients had csPCa. All the patients with PIRADS-3a (n = 37) had clinically insignificant tumors or benign conditions. Receiver operating characteristic curve analysis for predicting csPCa showed that the (Area under the curve) AUC values of PSAD, prostate volume, and prostate-specific antigen were 0.899, 0.746, and 0.381, respectively. 16 csPCa patients in PIRADS-3b category had PSAD ≥0.29 ng/ml2, whereas 1 patient had PSAD <0.29 ng/ml2. Sensitivity, specificity, PPV, and NPV of PIRADS-3b lesions were 100%, 40.66%, 23.94%, and 100%, respectively, and it became 94.12%, 74.07%, 53.33%, and 97.56%, respectively, when PSAD was added to PIRADS-3b lesions. Conclusion: The combination of lesion volume of the PI-RADS 3 lesion and PSAD improved the PPV and specificity of detecting csPCa.https://journals.lww.com/10.4103/iju.iju_112_24
spellingShingle Shashank Agrawal
Vishnu Prasad
Arun Ramadas Menon
Ginil Kumar Pooleri
Can lesion volume and prostate-specific antigen density play a role in detecting clinically significant prostate cancer in Prostate Imaging Reporting and Data System-3 lesions on multiparametric magnetic resonance imaging?
Indian Journal of Urology
title Can lesion volume and prostate-specific antigen density play a role in detecting clinically significant prostate cancer in Prostate Imaging Reporting and Data System-3 lesions on multiparametric magnetic resonance imaging?
title_full Can lesion volume and prostate-specific antigen density play a role in detecting clinically significant prostate cancer in Prostate Imaging Reporting and Data System-3 lesions on multiparametric magnetic resonance imaging?
title_fullStr Can lesion volume and prostate-specific antigen density play a role in detecting clinically significant prostate cancer in Prostate Imaging Reporting and Data System-3 lesions on multiparametric magnetic resonance imaging?
title_full_unstemmed Can lesion volume and prostate-specific antigen density play a role in detecting clinically significant prostate cancer in Prostate Imaging Reporting and Data System-3 lesions on multiparametric magnetic resonance imaging?
title_short Can lesion volume and prostate-specific antigen density play a role in detecting clinically significant prostate cancer in Prostate Imaging Reporting and Data System-3 lesions on multiparametric magnetic resonance imaging?
title_sort can lesion volume and prostate specific antigen density play a role in detecting clinically significant prostate cancer in prostate imaging reporting and data system 3 lesions on multiparametric magnetic resonance imaging
url https://journals.lww.com/10.4103/iju.iju_112_24
work_keys_str_mv AT shashankagrawal canlesionvolumeandprostatespecificantigendensityplayaroleindetectingclinicallysignificantprostatecancerinprostateimagingreportinganddatasystem3lesionsonmultiparametricmagneticresonanceimaging
AT vishnuprasad canlesionvolumeandprostatespecificantigendensityplayaroleindetectingclinicallysignificantprostatecancerinprostateimagingreportinganddatasystem3lesionsonmultiparametricmagneticresonanceimaging
AT arunramadasmenon canlesionvolumeandprostatespecificantigendensityplayaroleindetectingclinicallysignificantprostatecancerinprostateimagingreportinganddatasystem3lesionsonmultiparametricmagneticresonanceimaging
AT ginilkumarpooleri canlesionvolumeandprostatespecificantigendensityplayaroleindetectingclinicallysignificantprostatecancerinprostateimagingreportinganddatasystem3lesionsonmultiparametricmagneticresonanceimaging